Healthcare Stocks

How to stay healthy post retirement?

Post-retirement health

Highlights Personal health is one of the crucial aspects to embrace post-retirement plans. It is important to build a separate portfolio for post-retirement health expenses so that they do not consume the retirement savings. Retirement is ...

Read More...
ImpediMed Has Finally Completed The Sale Of One Of Its Assets, XiTRON Technologies Inc.

ImpediMed Has Finally Completed The Sale Of One Of Its Assets, XiTRON Technologies Inc.

ImpediMed Limited (ASX: IPD) has finally sold one of its asset named XiTRON technologies to Vitrek, LLC. The reason of the sale was that company finds certain opportunities with SOZO, which is a digital health platform and so that they can completely...

Read More...
Mesoblast Limited Shares Soar On Completion Of Partnership With China’s Tasly Pharmaceutical

Mesoblast Limited Shares Soar On Completion Of Partnership With China’s Tasly Pharmaceutical

Mesoblast Limited (ASX: MSB) rushed on Australian Securities Exchange after the group completed long standing strategic partnership deal with China?s Tasly Pharmaceutical Group. At the time of writing, the stock price of MSB has jumped as high as 3.2...

Read More...
Medical Developments International Limited – Green Signal For Penthrox In Saudi Arabia

Medical Developments International Limited – Green Signal For Penthrox In Saudi Arabia

After Medical Developments International Limited?s (ASX: MVP) exclusive deal for Penthrox in China , MVP has been ?granted marketing authorization for the Penthrox medicine in Kingdom of Saudi Arabia (KSA). This authorization is granted by Saudi Food...

Read More...
Clinuvel Pharmaceuticals Ltd advised on Appeal Against NICE Recommendation in England

Clinuvel Pharmaceuticals Ltd advised on Appeal Against NICE Recommendation in England

Clinuvel Pharmaceuticals Ltd (ASX: CUV) and other three consultee organisations representing the erythropoietic protoporphyria? patients (EPP patients) and expert physician requested the appeal hearing appointed by NICE (National Institute of Health ...

Read More...
Cochlear Announces Next Phase In Development Of Totally Implantable Cochlear Implant Technology

Cochlear Announces Next Phase In Development Of Totally Implantable Cochlear Implant Technology

Cochlear (ASX: COH) recently announced the next phase in long-term research and development program with the start of a further clinical feasibility study. A further clinical feasibility study has been initiated to evaluate the totally implantable co...

Read More...
Medibio (ASX: MEB) Introduces Corporate Health Product Named “Ilumen”

Medibio (ASX: MEB) Introduces Corporate Health Product Named “Ilumen”

Medibio Limited (ASX: MEB) from healthcare industry announces to introduce its new product ?ilumen? for corporate customers which has a capability to offer biometric analysis and objective, provide data-driven feedback as well assess mental wellness ...

Read More...
What’s Happening To Cochlear’s Share Price?

What’s Happening To Cochlear’s Share Price?

Cochlear Limited (ASX: COH) has been witnessing a strong downtrend since morning. At the time of writing, the stock price stands at A$191.040 per share which implies an intra-day fall of $11.340 or 5.603%. The stock price tumbled as a result of the F...

Read More...
Medical Developments International Entered Penthrox Agreement With China And Daiichi Sankyo

Medical Developments International Entered Penthrox Agreement With China And Daiichi Sankyo

Medical Developments International Limited (ASX: MVP) is happy to announce its agreement on Penthrox (a non-opioid analgesic used for pain relief for patients suffering from trauma or those requiring analgesics during surgeries) with Daiichi Sankyo l...

Read More...
Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

Medibio Announces Regarding Notice Received Under Section 249D Of The Corporations Act

On 1 October 2018, the Medibio Limited (ASX: MEB) announced that on 28 September it received a notice under Section 249D of the Corporations Act 2001 (Section 249D Notice) requesting the Company call and arrange to hold a meeting of the members of th...

Read More...
Capitol Health Provided Update Regarding Additional MRI Medicare License Process

Capitol Health Provided Update Regarding Additional MRI Medicare License Process

Capitol Health Ltd (ASX: CAJ) is mainly involved in the operations of providing imaging services in Australian Healthcare market. On 5 October 2018, the company provided an update regarding the Federal Government?s recent announcement about the pendi...

Read More...
Ad

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK